Primary |
Postoperative Care |
54.0% |
Preoperative Care |
22.3% |
Conjunctivitis |
3.4% |
Drug Use For Unknown Indication |
3.4% |
Prophylaxis |
2.0% |
Ulcerative Keratitis |
1.4% |
Atrial Fibrillation |
1.1% |
Blood Cholesterol Increased |
1.1% |
Cataract Operation |
1.1% |
Eye Infection |
1.1% |
Glaucoma Surgery |
1.1% |
Infection Prophylaxis |
1.1% |
Macular Degeneration |
1.1% |
Supplementation Therapy |
1.1% |
Type 1 Diabetes Mellitus |
1.1% |
Corneal Abrasion |
0.8% |
Hypertension |
0.8% |
Anaesthesia |
0.6% |
Blood Pressure |
0.6% |
Colitis |
0.6% |
|
Toxic Anterior Segment Syndrome |
28.6% |
Endophthalmitis |
8.3% |
Vision Blurred |
8.3% |
Ocular Hyperaemia |
7.1% |
Urticaria |
6.0% |
Drug Ineffective |
4.8% |
Eye Irritation |
4.8% |
Dry Eye |
3.6% |
Diarrhoea |
2.4% |
Dysgeusia |
2.4% |
Eye Pain |
2.4% |
Hallucination |
2.4% |
Hypersensitivity |
2.4% |
Lacrimation Increased |
2.4% |
Nasopharyngitis |
2.4% |
Nausea |
2.4% |
Pruritus Generalised |
2.4% |
Rash Generalised |
2.4% |
Visual Acuity Reduced |
2.4% |
Weight Decreased |
2.4% |
|
Secondary |
Postoperative Care |
27.4% |
Drug Use For Unknown Indication |
13.2% |
Preoperative Care |
8.9% |
Eye Laser Surgery |
7.9% |
Cataract Operation |
6.3% |
Prophylaxis |
5.3% |
Eye Pain |
3.7% |
Necrotising Scleritis |
3.2% |
Pseudomonas Infection |
3.2% |
Ulcerative Keratitis |
3.2% |
Atrial Fibrillation |
2.1% |
Episcleritis |
2.1% |
Herpes Zoster Ophthalmic |
2.1% |
Hypertension |
2.1% |
Ocular Hyperaemia |
2.1% |
Supplementation Therapy |
2.1% |
Macular Degeneration |
1.6% |
Transplant |
1.6% |
Blood Cholesterol Increased |
1.1% |
Corneal Erosion |
1.1% |
|
Inflammation |
31.3% |
Endophthalmitis |
11.9% |
Iridocyclitis |
9.0% |
Keratitis |
4.5% |
Petechiae |
4.5% |
Visual Acuity Reduced |
4.5% |
Dysgeusia |
3.0% |
Nasopharyngitis |
3.0% |
Nausea |
3.0% |
Ocular Hyperaemia |
3.0% |
Pseudomonas Infection |
3.0% |
Stevens-johnson Syndrome |
3.0% |
Toxic Anterior Segment Syndrome |
3.0% |
Urticaria |
3.0% |
Vision Blurred |
3.0% |
Cataract |
1.5% |
Corneal Erosion |
1.5% |
Corneal Infiltrates |
1.5% |
Cough |
1.5% |
Diarrhoea |
1.5% |
|
Concomitant |
Drug Use For Unknown Indication |
31.7% |
Product Used For Unknown Indication |
12.7% |
Macular Degeneration |
6.9% |
Postoperative Care |
6.3% |
Prophylaxis |
5.8% |
Nausea |
3.2% |
Contraception |
2.9% |
Diabetes Mellitus |
2.6% |
Endometriosis |
2.6% |
Gastrooesophageal Reflux Disease |
2.6% |
Genital Haemorrhage |
2.6% |
Myelodysplastic Syndrome |
2.6% |
Pelvic Pain |
2.6% |
Endophthalmitis |
2.3% |
Eye Disorder |
2.3% |
Glaucoma |
2.3% |
Pain |
2.3% |
Metastatic Squamous Cell Carcinoma |
2.0% |
Non-small Cell Lung Cancer |
2.0% |
Back Pain |
1.7% |
|
Vitritis |
11.3% |
Vomiting |
10.4% |
Endophthalmitis |
8.5% |
Visual Acuity Reduced |
6.6% |
Weight Increased |
6.6% |
Corneal Disorder |
5.7% |
Impaired Healing |
5.7% |
Keratitis |
4.7% |
Toothache |
4.7% |
Unresponsive To Stimuli |
4.7% |
Pneumonia Aspiration |
3.8% |
Punctate Keratitis |
3.8% |
Urinary Tract Infection |
3.8% |
Chest Pain |
2.8% |
Death |
2.8% |
Economic Problem |
2.8% |
Pneumonia |
2.8% |
Stomatitis |
2.8% |
Ulcerative Keratitis |
2.8% |
Vision Blurred |
2.8% |
|